Intermittent fasting doesn’t have an edge for weight loss, but might still work for some 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil 
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 
This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands (volume) and US$ Thousand (value) by the following Product Segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 42 companies including many key and niche players such as
- Abbott Laboratories, Inc. (US)
- Abbott Molecular, Inc. (US)
- Adaltis S.r.l. (Italy)
- Alere (US)
- Beckman Coulter, Inc. (US)
- bioMérieux SA (France)
- Bio-Rad Laboratories, Inc. (US)
- Calypte Biomedical Corporation (US)
- Chembio Diagnostic Systems, Inc. (US)
- Hologic, Inc. (US)
- Fujirebio Europe N.V. (Belgium)
- MedMira Inc. (Canada)
- OraSure Technologies, Inc. (US)
- Ortho-Clinical Diagnostics, Inc. (US)
- Quest Diagnostics, Inc. (US)
- Roche Diagnostics (Switzerland)
- Siemens Healthcare Diagnostics, Inc. (US)
- Trinity Biotech Plc. (Ireland)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. GROWTH DRIVERS AND MARKET TRENDS
3. HIV/AIDS STATISTICS
4. HIV/AIDS: UNDERSTANDING THE DISEASE
5. DIAGNOSIS OF HIV/AIDS
6. PRODUCT APPROVALS & LAUNCHES
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT GLOBAL PLAYERS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 42 (including Divisions/Subsidiaries - 47)
- The United States (33)
- Canada (2)
- Europe (8)
- - France (2)
- - Italy (2)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (4)
For more information visit http://www.researchandmarkets.com/research/cq3kt5/hivaids_testing
CONTACT: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Infectious Disease Testing
